The following documents have been filed with the SEC:
SEC Filing Alert
10-Q: Quarterly report pursuant to Section 13 or 15(d)
HTML
PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
Immunovant, Inc.320 W 37th Street, 6th Floor, New York, NY 10018 United States of America
https://immunovant.com